Latest National Prostate Health Month Stories

HACKENSACK, N.J.; Aug. 24 /PRNewswire-USNewswire/ -- Virgil H. Simons, Founder and President of The Prostate Net announced the organization's latest major initiative in the fight against prostate cancer. A day-long, dual-track educational symposium targeting patients, caregivers and medical professionals will take place on Tuesday, October 6, 2009 at New York University, Kimmel Center for University Life in New York City. Joined by Keynote Speaker, Donald Coffey, PhD, from Johns Hopkins...

ZERO - The Project to End Prostate Cancer Brings Awareness Across Country; Partnership with Depend Helps Raise Money for the Cause WASHINGTON, June 17 /PRNewswire-USNewswire/ -- Zero prostate cancer deaths. Zero prostate cancer cases and for those with prostate cancer, it means a zero PSA. The name says it all -- zero tolerance for prostate cancer. To kick off its summer end prostate cancer tour, ZERO is pleased to announce its partnership with Kimberly-Clark Corporation and the Depend...

WASHINGTON, April 29 /PRNewswire-USNewswire/ -- The recent announcement of the REDUCE trial results at the American Urological Association annual meeting in Chicago brings optimism to the prostate cancer community as dutasteride (Avodart), a drug used to treat benign prostatic hyperplasia, has shown to lower by 23 percent the risk of prostate cancer in men with an increased risk of the disease. Men's Health Network looks forward to this becoming an additional tool in the fight against...

DENVER, April 27 /PRNewswire-USNewswire/ -- Phase II data presented at the annual meeting of the American Urology Association (AUA) indicate that men suffering from an enlarged prostate may benefit from BOTOX(R) injections. The two-stage, multi-center, double-blind, randomized study showed that two different dose levels of Botulinium Neurotoxin Type A (BOTOX) injected into the prostate was both safe and efficacious for the management of benign prostatic hyperplasia (BPH), a common...

WASHINGTON, April 6 /PRNewswire-USNewswire/ -- The prostate cancer education and advocacy community has come together to collaborate on and develop a shared agenda in the interests of the hundreds of thousands of American men who are at risk for a diagnosis of prostate cancer every year. The leadership from eight leading prostate cancer organizations met on April 2, in Washington, DC, to explore how to effectively work together on specific policy initiatives to advocate for early detection...

WASHINGTON, March 23 /PRNewswire-USNewswire/ -- Since 1993, when the PLCO trial was started, we have awaited the results of this trial with eager anticipation, as have others. The initial report of the results of this study -- and those of a comparable European trial -- published last week in the New England Journal of Medicine have told us two things: * The studies offer conflicting evidence about the possibility of a prostate cancer-specific survival benefit associated with the regular...

Celebrity duo bring sports flavor to the conversation about a serious men's health threat CARY, N.C., Dec. 4 /PRNewswire/ -- College basketball analyst and sports ambassador Dick Vitale and co-host of ESPN's Pardon the Interruption Michael Wilbon have teamed up with ESPN, The V Foundation for Cancer Research(R) and Stand Up To Cancer(TM) in an effort to create a national discussion about the often ignored reality of prostate cancer and to help men start to understand their potential...

To: NATIONAL EDITORS Contact: Candace Sandy of the Office of U.S. Rep. Gregory Meeks, +1-202-225-3461 (office), +1-718-683-4209 (mobile) September is Prostate Cancer Awareness Month Congressional leaders from the states that suffer the highest prostate cancer death rates for black men convene September 25-26 to look at reasons why African Americans have a 60% higher incidence rate of prostate cancer than all other men, resulting in a 150% higher mortality rate. WASHINGTON, Sept. 24...

National Prostate Cancer Awareness Month is an opportunity to underscore our commitment to fighting prostate cancer and to raise awareness about this highly treatable disease. Prostate cancer is the second most common type of cancer found in men, and one in six men will develop it during their lifetime. The cause of prostate cancer remains unknown, but early detection can lead to better treatment and increase the chances of survival. It is important for men to talk to their physicians...

While Olympic athletes will begin vying for champion status this weekend in Beijing, Skip Ciccarelli, a 60-year-old survivor of prostate cancer, will complete his own Olympian effort. When he paddles up to New York's Pier 66 at noon on Saturday, he will be completing a 1,700 mile, 54-day kayak trek to raise awareness for prostate cancer--one of the most prevalent forms of cancer, second only to melanomas. The day also marks the seventh anniversary of his prostatectomy. In everyday life...